Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study.

导出 OA

翻译打印收藏纠错

第一作者： Ozgur Can,Eren

第一单位： Department of Pathology, Koç University School of Medicine, Istanbul, Turkey.

作者： Ozgur Can,Eren ^[1] ; Cisel Aydin,Mericoz ^[2] ; Emine,Bozkurtlar ^[3] ; Pinar,Bulutay ^[1] ; Arzu,Baygul ^[4] ; Ibrahim,Kulac ^[1]

作者单位： Department of Pathology, Koç University School of Medicine, Istanbul, Turkey. ^[1] Department of Immunology, Graduate School of Health Sciences, Koç University, Istanbul, Turkey. ^[2] Koç University IsBank Research Center for Infectious Diseases, Istanbul, Turkey. ^[3] Department of Pathology, Marmara University School of Medicine, Istanbul, Turkey. ^[4] Department of Biostatistics, Koç University School of Medicine, Istanbul, Turkey. ^[5] Research Center for Translational Medicine, Koç University, Istanbul, Turkey. ^[6]

关键词 ALK D5F3 ALK OTI1A4 immunohistochemistry lung adenocarcinoma predictive testing validation

主题词人类(Humans);肺肿瘤(Lung Neoplasms);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);回顾性研究(Retrospective Studies);免疫组织化学(Immunohistochemistry);原位杂交, 荧光(In Situ Hybridization, Fluorescence);基因重排(Gene Rearrangement)

DOI 10.1093/ajcp/aqad111

PMID 37681660

发布时间 2024-01-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交